Erratum: Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D serum levels in systemic sclerosis (PLoS ONE (2014) 10:9 (e0137912) 10.1371/journal.pone.0137912);Relationship between body mass composition, bone mineral density, skin fibrosis and 25(OH) Vitamin D serum levels in Systemic Sclerosis

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Corrado, Addolorata ^a   Colia, Ripalta ^a   Mele, Angiola ^a   Di Bello, Valeria ^a   Trotta, Antonello ^a   Neve, Anna ^a   Cantatore, Francesco Paolo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; CORTICOSTEROID; PARATHYROID HORMONE; PHOSPHORUS; PREDNISONE; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY COMPOSITION; BODY MASS; BONE DENSITY; CALCIUM BLOOD LEVEL; DISEASE DURATION; DRUG RESPONSE; FAT MASS; FEMALE; FEMUR NECK; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; PHOSPHATE BLOOD LEVEL; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREVALENCE; SKIN FIBROSIS; SKINFOLD THICKNESS; SYSTEMIC SCLEROSIS; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; BONE DISEASES, METABOLIC; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPLICATION; FIBROSIS; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SKIN DISEASES;

ADULT; AGED; BODY COMPOSITION; BONE DENSITY; BONE DISEASES, METABOLIC; CASE-CONTROL STUDIES; FEMALE; FIBROSIS; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PROGNOSIS; SCLERODERMA, SYSTEMIC; SKIN DISEASES; VITAMIN D;

EID: 84945929620     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142748     Document Type: Erratum

References (33)

1. Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol 2011; 40:78-83.
2. Frediani B, Baldi F, Falsetti P, Acciai C, Filippou G, Spreafico A, et al. Bone mineral density in patients with systemic sclerosis. Ann Rheum Dis 2004; 63:326-7.
3. Carbone L, Tylavsky F, Wan J, McKown K, Cheng S. Bone mineral density in scleroderma. Rheumatology (Oxford) 1999; 37:1-2.
4. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84:18-28.
5. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-A review of recent evidence. Autoimmun Rev 2013; 12:976-89
6. Wacker M, Holick MF. Vitamin D effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 2013; 5:111-48.
7. Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol 2013; 45:256-66.
8. Amital H, Szekanecz Z, Szucs G, Dankó K, Nagy E, Csépány T, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010; 69:1155-7.
9. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007; 56:2143-9.
10. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296:2832-8.
11. Shimada A, Kanazawa Y, Motohashi Y, Yamada S, Maruyama T, Ikegami H, et al. Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J Autoimmun 2008; 30:207-11.
12. Di Munno O, Mazzantini M, Massei P, Ferdeghini M, Pitaro N, Latorraca A, et al. Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 1995; 14:407-12.
13. Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MB. The Rapid Assessment of Physical Activity (RAPA) among older adults. Prev Chronic Dis 2006; 3:A118.
14. Coghlan JG, Denton CP, Grönig E, Bonderman D, Distler O, Khanna D, et al; DETECT study group. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: The DETECT study. Ann Rheum Dis. 2014; 73:1340-9. doi: 10.1136/annrheumdis-2013-203301
15. Omair MA, Pagnoux C, McDonald-Blumer H, Johnson SR. Low bone density in systemic sclerosis. A systematic review. The Journal of rheumatology. 2013 40:1881-90. doi: 10.3899/jrheum.130032
16. La Montagna G, Vatti M, Valentini G, Tirri G. Osteopenia in systemic sclerosis. Evidence of a participating role of earlier menopause. Clin Rheumatol 1991; 10:18-22.
17. Atteritano M, Sorbara S, Bagnato G, Miceli G, Sangari D, Morgante S, et al. Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: A case control study. PLoS One. 2013; 8:e66991. doi: 10.1371/journal.pone.0066991
18. Sampaio-Barros PD, Costa-Paiva L, Filardi S, Sachetto Z, Samara AM, Marques-Neto JF. Prognostic factors of low bone mineral density in systemic sclerosis. Clin Exp Rheumatol 2005; 23:180-4
19. Frediani B, Baldi F, Falsetti P, Acciai C, Filippou G, Spreafico A, et al. Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis. Clin Exp Rheumatol 2004; 22:313-8.
20. Souza RB, Borges CT, Takayama L, Aldrighi JM, Pereira RM. Systemic sclerosis and bone loss: The role of the disease and body composition. Scand J Rheumatol 2006; 35:384-7.
21. Mouyis M, Ostor AJ, Crisp AJ, Ginawi A, Halsall DJ, Shenker N, et al. Hypovitaminosis D among rheumatologic outpatients in clinical practice. Rheumatology 2008; 47:1348-1351. doi: 10.1093/rheumatology/ken203
22. Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008; 67:530-535.
23. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006; 5:114-17.
24. Maruotti N, Cantatore FP. Vitamin D and the immune system. J Rheumatol 2010; 37:491-5. doi: 10. 3899/jrheum.090797
25. Hajas A, Sandor J, Csathy L, Csipo I, Barath S, Paragh G, et al. Vitamin D insufficiency in a large MCTD population. Autoimmun Rev 2011; 10:317-22. doi: 10.1016/j.autrev.2010.11.006
26. Caramaschi P, Dalla Gassa A, Ruzzenente O, Volpe A, Ravagnani V, Tinazzi I, et al. Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol 2010; 29:1419-25. doi: 10.1007/s10067-010-1478-3
27. Arnson Y, Amital H, Agmon-Levin N, Alon D, Sánchez-Castañón M, López-Hoyos M, et al. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: A retrospective cohort study and review of the literature. Autoimmun Rev 2011; 10:490-4. doi: 10.1016/j.autrev.2011.02.002
28. Solomon JJ, Olson AL, Fischer A, Bull T, Brown KK, Raghu G. Scleroderma lung disease. Eur Respir Rev. 2013 Mar 1; 22(127):6-19. doi: 10.1183/09059180.00005512
29. Ibn Yacoub Y, Amine B, Laatiris A, Wafki F, Znat F, Hajjaj-Hassouni N. Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status. Rheumatol Int 2012; 32:3143-8.
30. Marie I, Ducrotté P, Denis P, Menard JF, Levesque H. Small intestinal bacterial overgrowth in systemic sclerosis. Rheumatology (Oxford).2009; 48:1314-9.
31. Avouac J, Koumakis E, Toth E, Meunier M, Maury E, Kahan A al. Increased risk of osteoporosis and fracture in women with systemic sclerosis: A comparative study with rheumatoid arthritis. Arthritis Care Res 2012; 64:1871-8.
32. Artaza JN, Norris KC. Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol 2009; 200:207-221. doi: 10.1677/JOE-08-0241
33. Ramirez AM, Wongtrakool C, Welch T, Steinmeyer A, Zugel U, Roman J. Vitamin D inhibition of profibrotic effects on transforming growth factor β1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol 2010; 118:142-15. doi: 10.1016/j.jsbmb.2009.11.004